Literature DB >> 1730469

Circulating and localized immune complexes in experimental mycoplasma-induced arthritis-associated ocular inflammation.

C E Thirkill1, N K Tyler, A M Roth.   

Abstract

Ocular deposits of immune complexes are believed to contribute to the anterior segment inflammations observed in association with the human arthritides. Arthritis-related ocular inflammations may be reproduced in animals by infection with certain species of mycoplasma. To evaluate the role of immune complexes in the production of ocular lesions, we studied their involvement in the rodent model of experimental arthritis-associated ocular inflammation induced by Mycoplasma arthritidis. Sprague-Dawley rats were infected with viable concentrates of M. arthritidis and monitored for the production of related circulating and intraocular immune complexes. Circulating immune complexes were monitored by antigen capture systems, and localized intraocular complexes were identified by indirect immunohistochemistry. Polyacrylamide gel immunoblot analysis of captured complexes confirmed the antigen(s) involved as proteins derived from M. arthritidis. Indirect immunofluorescence revealed localized complexes containing mycoplasma antigens within the ciliary-iris vasculature. Concentrations of the generated complexes diminished rapidly over a 30-day period. While complex deposits within ocular tissues could represent a contributing cause to the localized anterior segment inflammation reported in this rodent model, secondary challenge with viable M. arthritidis, which reproduced high concentrations of intraocular and circulating immune complexes, failed to elicit any ocular response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730469      PMCID: PMC257642          DOI: 10.1128/iai.60.2.401-405.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

Review 1.  Anti-DNA antibodies and lupus nephritis: the complexity of crossreactivity.

Authors:  K Brinkman; R Termaat; J H Berden; R J Smeenk
Journal:  Immunol Today       Date:  1990-07

2.  Interactions of cultured rat synovial and ocular ciliary body cells with two strains of Mycoplasma arthritidis.

Authors:  C E Thirkill; A M Roth; R J Munn; P Lee; N K Tyler
Journal:  In Vitro Cell Dev Biol       Date:  1990-02

3.  Diphtheroid-like properties of Mycoplasma arthritidis.

Authors:  C E Thirkill; D S Gregerson
Journal:  Med Lab Sci       Date:  1986-01

4.  Arthritis in calves caused by mycoplasmas.

Authors:  Y a Buchvarova; A Vesselinova
Journal:  Arch Exp Veterinarmed       Date:  1986-01

5.  Hepatitis B virus infection: detection of circulating HBsAg/IgM antibody immune complexes.

Authors:  P Surelia; E H Boxall
Journal:  Med Lab Sci       Date:  1990-07

Review 6.  Protein blotting: principles and applications.

Authors:  J M Gershoni; G E Palade
Journal:  Anal Biochem       Date:  1983-05       Impact factor: 3.365

7.  Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis (MAM). VIII. Selective activation of T cells expressing distinct V beta T cell receptors from various strains of mice by the "superantigen" MAM.

Authors:  B C Cole; D R Kartchner; D J Wells
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

8.  Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. V. A small basic protein from culture supernatants is a potent T cell mitogen.

Authors:  C L Atkin; B C Cole; G J Sullivan; L R Washburn; B B Wiley
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

9.  Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis.

Authors:  D C Dumonde; E Kasp-Grochowska; E Graham; M D Sanders; J P Faure; Y de Kozak; V van Tuyen
Journal:  Lancet       Date:  1982-10-09       Impact factor: 79.321

10.  Immunosuppressive properties of the Mycoplasma arthritidis T-cell mitogen in vivo: inhibition of proliferative responses to T-cell mitogens.

Authors:  B C Cole; D J Wells
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.